Raphael Pharmaceutical Cash Flow Statement (2020-2025) | RAPH

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-0.25M-0.39M-0.42M-1.82M-0.17M-0.61M-1.43M-1.83M-0.26M-0.42M-0.73M-1.14M-0.55M-0.25M-0.32M-1.93M
Depreciation and Depletion (Quarter)
0.00M
Share-based Compensation (Quarter)
0.15M0.14M1.20M-1.34M0.29M0.20M0.01M0.04M0.00M
Cash from Operations (Quarter)
-0.13M-0.30M-0.28M-0.70M-0.08M-0.25M-0.15M-0.28M-0.40M-0.21M-0.50M-0.09M-0.17M-0.22M-0.08M-0.06M-0.21M-0.03M-0.02M0.05M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.00M
Change in Working Capital
Change in Account Payables (Quarter)
0.03M-0.02M0.13M-0.13M-0.07M0.00M0.11M-0.06M-0.07M-0.10M0.42M-0.22M0.38M-0.04M0.25M-0.41M0.06M0.28M0.19M0.29M
Change in Accured Expenses (Quarter)
0.00M0.03M
Other Working Capital Changes (Quarter)
-0.10M-0.10M-0.00M0.24M-0.17M-0.09M0.01M0.02M0.07M-0.10M-0.00M0.00M0.01M-0.01M0.00M-0.00M0.04M-0.03M-0.01M
Investing Activities
Capital Expenditures (Quarter)
0.00M
Cash from Investing Activities (Quarter)
-0.00M
Financing Activities
Other financing activities (Quarter)
0.01M0.05M
Cash from Financing Activities (Quarter)
0.04M0.51M0.10M0.82M0.01M0.30M0.11M0.47M0.15M0.29M0.69M0.02M0.23M0.05M0.04M0.24M-0.00M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.11M0.81M0.02M0.18M0.10M0.24M0.00M
Additional items
Change in Cash (Quarter)
-0.09M0.21M-0.18M0.12M-0.07M0.05M-0.04M0.20M-0.25M0.07M0.19M-0.07M0.06M-0.17M-0.08M-0.02M0.03M-0.03M-0.02M0.04M
Free Cash Flow (Quarter)
-0.13M-0.30M-0.28M-0.70M-0.08M-0.25M-0.15M-0.28M-0.40M-0.21M-0.50M-0.09M-0.17M-0.22M-0.08M-0.06M-0.21M-0.03M-0.02M0.05M
Net Cash Flow (Quarter)
-0.09M0.21M-0.18M0.12M-0.07M0.05M-0.04M0.20M-0.25M0.07M0.19M-0.07M0.06M-0.17M-0.08M-0.02M0.03M-0.03M-0.02M0.04M